Pharmaceutical Medical Technology Fund - PMTF New York

Welcome to Pharmaceutical Medical Technology Fund

Pharmaceutical Medical Technology Fund's senior team of experts have decades of experience in life sciences research and drug and diagnostic discovery and development. Our mission is to assist our clients in conducting exceptional-quality research to advance human health, particularly through the facilitation of personalized medicine.

We believe you should expect the best from your R&D partner, and that is exactly what we seek to achieve in four key areas:

Quality. Quality is at the core of every decision we make. As scientists and former CRO customers, we understand it is critical for us to offer only the highest-quality staff, facilities, oversight, compliance and results--and we are committed to delivering on that promise every day.

Expertise. Members of our management team are among the foremost leaders in biomarker research in the U.S., which means we can offer a level of highly specialized services not widely available as well as guide you in best practices in the field.

Responsiveness. We know how frustrating it is to lock in on terms, space and staff when there are constantly changing variables affecting R&D needs. That's why we are committed to offering our customers maximum flexibility in terms of space, staffing and support, and experimental approach to make things easier, not more complicated.

Solutions. Because we are scientists ourselves, we understand the goals that are driving your experiments. At Pharmaceutical Medical Technology Fund, we are committed to advancing your R&D program to ensure you receive meaningful results and not just more questions.

Pharmaceutical Medical Technology Fund provides in vitro and in vivo preclinical drug development services including experimental design and testing, animal and cellular disease models, cell line development and protein production, selection and validation of biomarkers, and vivarium services. With deep expertise in drug development, the company offers access to their top scientists who work collaboratively with researchers to expedite preclinical and clinical therapeutic development.